Alain Morere

Prof. Dr. Alain Morere


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KCKhaled El Cheikh
Khaled El Cheikh
IBIlaria Basile
Ilaria Basile
ASAfitz Da Silva
Afitz Da Silva
CBCoralie Bernon
Coralie Bernon
PCPierre Cérutti
Pierre Cérutti
AMAlain Morere
Alain Morere

1 January 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
IBIlaria Basile
Ilaria Basile
ASAfitz Da Silva
Afitz Da Silva
KCKhaled El Cheikh
Khaled El Cheikh
AGAnastasia Godefroy
Anastasia Godefroy
MDMorgane Daurat
Morgane Daurat
MMMarie Maynadier
Marie Maynadier

Verified
Journal Article
Open access
PDF file
EBElise Bouffard
Elise Bouffard
CJChiara Mauriello Jimenez
Chiara Mauriello Jimenez
KCKhaled El cheikh
Khaled El cheikh
MMMarie Maynadier
Marie Maynadier
IBIlaria Basile
Ilaria Basile
AMAlain Morere
Alain Morere
The aim of the present work is the development of highly efficient targeting molecules to specifically address mesoporous silica nanoparticles (MSNs) designed for the photodynamic therapy (PDT) of prostate cancer. We chose the strategy to develop a novel compound that allows the improvement of the targeting of the cation-independent mannose 6-phosphate receptor, which is overexpressed in prostate cancer. This original sugar, a dimannoside-carboxylate (M6C-Man) grafted on the surface of MSN for PDT applications, leads to a higher endocytosis and thus increases the efficacy of MSNs.

8 February 2022 in Industrial Crops and Products
Verified
Journal Article
Closed access
SYSonia Yahiaoui
Sonia Yahiaoui
DKDjamel-Edine Kati
Djamel-Edine Kati
LALamiaa M.A. Ali
Lamiaa M.A. Ali
KCKhaled El Cheikh
Khaled El Cheikh
AMAlain Morere
Alain Morere
NBNadir Bettache
Nadir Bettache

23 September 2017 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Wei LIUWei LIU
Wei LIU
ACArnaud Chaix
Arnaud Chaix
MGMagali Gary-Bobo
Magali Gary-Bobo
BABernard Angeletti
Bernard Angeletti
AMArmand Masion
Armand Masion
MAMelanie Auffan
Melanie Auffan
A challenge regarding the design of nanocarriers for drug delivery is to prevent their recognition by the immune system. To improve the blood residence time and prevent their capture by organs, nanoparticles can be designed with stealth properties using polymeric coating. In this study, we focused on the influence of surface modification with polyethylene glycol and/or mannose on the stealth behavior of porous silicon nanoparticles (pSiNP, ~200 nm). In vivo biodistribution of pSiNPs formulations were evaluated in mice 5 h after intravenous injection. Results indicated that the distribution in the organs was surface functionalization-dependent. Pristine pSiNPs and PEGylated pSiNPs were distributed mainly in the liver and spleen, while mannose-functionalized pSiNPs escaped capture by the spleen, and had higher blood retention. The most efficient stealth behavior was observed with PEGylated pSiNPs anchored with mannose that were the most excreted in urine at 5 h. The biodegradation kinetics evaluated in vitro were in agreement with these in vivo observations. The biocompatibility of the pristine and functionalized pSiNPs was confirmed in vitro on human cell lines and in vivo by cytotoxic and systemic inflammation investigations, respectively. With their biocompatibility, biodegradability, and stealth properties, the pSiNPs functionalized with mannose and PEG show promising potential for biomedical applications.

22 August 2022 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
LALamiaa M.A. Ali
Lamiaa M.A. Ali
KMKazuya Miyagawa
Kazuya Miyagawa
NFNorihito Fukui
Norihito Fukui
MOMélanie Onofre
Mélanie Onofre
KCKhaled El Cheikh
Khaled El Cheikh
HSHiroshi Shinokubo
Hiroshi Shinokubo
5,15-Diazaporphyrin appended with d -mannose moieties was prepared through Suzuki–Miyaura cross-coupling reaction and S N 2 alkylation.